Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Drug exec Shkreli will not answer questions at hearing: letter
EDIT: New Reuters Story - Original headline: EX-DRUG CEO MARTIN SHKRELI PLANS TO NOT ANSWER QUESTIONS AT CONGRESSIONAL HEARING NEXT WEEK -LETTER
Source: Reuters
Business News | Thu Jan 21, 2016 3:22pm EST
Drug exec Shkreli will not answer questions at hearing: letter
NEW YORK | BY NATE RAYMOND AND DAVID INGRAM
Former drug executive Martin Shkreli plans to assert his right against self-incrimination and remain silent if he is forced to appear next week at a congressional hearing about drug prices, according to a letter seen by Reuters.
Shkreli's lawyer informed the U.S. House Committee on Oversight and Government Reform of his intent not to answer questions and asked that Shkreli be excused from appearing, committee chairman Jason Chaffetz wrote in the letter dated Wednesday to his lawyer, Baruch Weiss.
Shkreli, who created a fire storm last year after raising the price of Daraprim, a life-saving medicine by more than 5,000 percent, is also facing federal criminal charges that he defrauded investors.
Chaffetz, a Utah Republican, wrote to Weiss that Shkreli could face criminal prosecution for contempt if he fails to appear at the hearing, scheduled for Tuesday. "Mr. Shkreli is uniquely qualified to answer questions about rising prescription drug prices," Chaffetz wrote.
Shkreli told lawmakers on Twitter on Thursday: "Your attempt to subvert my constitutional right to the 5th amendment are disgusting & insulting to all Americans."
[font size=1]-snip-[/font]
Drug exec Shkreli will not answer questions at hearing: letter
NEW YORK | BY NATE RAYMOND AND DAVID INGRAM
Former drug executive Martin Shkreli plans to assert his right against self-incrimination and remain silent if he is forced to appear next week at a congressional hearing about drug prices, according to a letter seen by Reuters.
Shkreli's lawyer informed the U.S. House Committee on Oversight and Government Reform of his intent not to answer questions and asked that Shkreli be excused from appearing, committee chairman Jason Chaffetz wrote in the letter dated Wednesday to his lawyer, Baruch Weiss.
Shkreli, who created a fire storm last year after raising the price of Daraprim, a life-saving medicine by more than 5,000 percent, is also facing federal criminal charges that he defrauded investors.
Chaffetz, a Utah Republican, wrote to Weiss that Shkreli could face criminal prosecution for contempt if he fails to appear at the hearing, scheduled for Tuesday. "Mr. Shkreli is uniquely qualified to answer questions about rising prescription drug prices," Chaffetz wrote.
Shkreli told lawmakers on Twitter on Thursday: "Your attempt to subvert my constitutional right to the 5th amendment are disgusting & insulting to all Americans."
[font size=1]-snip-[/font]
Read more: http://www.reuters.com/article/us-usa-crime-shkreli-idUSKCN0UZ2O3
Source: FierceBiotech
'I have constitutional rights,' tweets Martin Shkreli, defying Senate subpoena
January 21, 2016 | By John Carroll
Over the past three months, Martin Shkreli rarely passed up an opportunity to publicly mock his critics or justify a 5000%-plus price hike on a 62-year-old generic. He took to television, Twitter and a live stream online to repeatedly defend his position, claim he was planning to lower the price of Daraprim, renege on the promise and declare his innocence after being charged with multiple counts of securities fraud.
But when it comes to a Senate probe into the price hike, Shkreli is taking the 5th.
U.S. Senator Susan Collins from Maine tweeted Wednesday evening that Shkreli is invoking his rights guarding him from self-incrimination, refusing to hand over documents her committee had subpoenaed for their probe into drug pricing. The move came shortly after a House committee subpoenaed Shkreli to testify at a hearing next week.
And Collins has a problem with Shkreli's position.
"Counsel informed our Committee that Mr. Shkreli was categorically invoking the 'Act of Production Privilege' under the Fifth Amendment," Collins tweeted. "Absent a valid justification for the grounds for invoking the Fifth Amendment, Mr. Shkreli's assertion could hinder our investigation."
[font size=1]-snip-[/font]
January 21, 2016 | By John Carroll
Over the past three months, Martin Shkreli rarely passed up an opportunity to publicly mock his critics or justify a 5000%-plus price hike on a 62-year-old generic. He took to television, Twitter and a live stream online to repeatedly defend his position, claim he was planning to lower the price of Daraprim, renege on the promise and declare his innocence after being charged with multiple counts of securities fraud.
But when it comes to a Senate probe into the price hike, Shkreli is taking the 5th.
U.S. Senator Susan Collins from Maine tweeted Wednesday evening that Shkreli is invoking his rights guarding him from self-incrimination, refusing to hand over documents her committee had subpoenaed for their probe into drug pricing. The move came shortly after a House committee subpoenaed Shkreli to testify at a hearing next week.
And Collins has a problem with Shkreli's position.
"Counsel informed our Committee that Mr. Shkreli was categorically invoking the 'Act of Production Privilege' under the Fifth Amendment," Collins tweeted. "Absent a valid justification for the grounds for invoking the Fifth Amendment, Mr. Shkreli's assertion could hinder our investigation."
[font size=1]-snip-[/font]
Read more: http://www.fiercebiotech.com/story/i-have-constitutional-rights-tweets-martin-shkreli-defying-senate-subpoena/2016-01-21
2 replies
= new reply since forum marked as read
= new reply since forum marked as read
Just answer every question with "I'm just doing this so I don't get fined."
